$1bn Deal Boosts Takeda, Arrowhead’s Liver Disease And RNAi Ambitions

Follows Promising Recent Clinical Data

 
• By Ian Haydock
Conceptual image of liver damage as a result of drugs, viruses, toxins, bacteria, parasites, 3D illustration - Illustration
Takeda Builds Liver Disease Interests With Arrowhead Deal • Source: Shutterstock

More from Business

More from Scrip